Spotlight environmental sustainability: a strategic priority for NICE.

environmental health policy health technology appraisal sustainability sustainable healthcare

Journal

Journal of public health (Oxford, England)
ISSN: 1741-3850
Titre abrégé: J Public Health (Oxf)
Pays: England
ID NLM: 101188638

Informations de publication

Date de publication:
01 12 2022
Historique:
received: 27 06 2022
revised: 27 06 2022
received: 08 07 2022
pubmed: 20 8 2022
medline: 6 12 2022
entrez: 19 8 2022
Statut: ppublish

Résumé

This article provides the context for the ambition outlined in the the National Institute for Health and Care Excellence (NICE) 2021-2026 strategy to 'lead globally on the potential to include environmental impact data in its guidance to reduce the carbon footprint of health and care'. Anthropogenic environmental changes pose a catastrophic risk to human health, with potential to widen national and global health inequalities. Recognising the fact that NICE guidance influences the way health and care is delivered and its consequent environmental impact, NICE has included environmental sustainability among its strategic priorities. This article outlines the work underway to meet this sustainability agenda at NICE.

Identifiants

pubmed: 35983710
pii: 6671209
doi: 10.1093/pubmed/fdac077
pmc: PMC9715298
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e593-e595

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Lancet Planet Health. 2021 Feb;5(2):e66-e68
pubmed: 33581064
Lancet Planet Health. 2022 Mar;6(3):e184-e185
pubmed: 35278382
Environ Health. 2017 Dec 5;16(Suppl 1):113
pubmed: 29219089
Lancet Planet Health. 2021 Feb;5(2):e84-e92
pubmed: 33581070
Lancet. 2015 Nov 7;386(10006):1861-914
pubmed: 26111439

Auteurs

Manuj Sharma (M)

Public Health Registrar, Health and Social Care, NICE.

Sarah Walpole (S)

National Medical Director's Clinical Fellow, Health and Social Care, NICE; Infectious Diseases and General Medicine SpR, North East of England; Associate Clinical Lecturer, Newcastle University.

Koonal Shah (K)

Associate Director, Science Policy and Research Programme, NICE.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH